Teligent Gross Margin 2010-2021 | TLGT

Current and historical gross margin for Teligent (TLGT) over the last 10 years. The current gross profit margin for Teligent as of June 30, 2021 is %.
Teligent Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2021-06-30 $0.05B $-0.01B -19.57%
2021-03-31 $0.05B $-0.00B -6.00%
2020-12-31 $0.05B $-0.00B -6.67%
2020-09-30 $0.05B $0.00B 7.84%
2020-06-30 $0.06B $0.01B 20.00%
2020-03-31 $0.06B $0.02B 28.81%
2019-12-31 $0.07B $0.02B 36.92%
2019-09-30 $0.07B $0.03B 42.42%
2019-06-30 $0.07B $0.03B 42.42%
2019-03-31 $0.06B $0.02B 37.50%
2018-12-31 $0.07B $0.02B 34.85%
2018-09-30 $0.06B $0.02B 35.00%
2018-06-30 $0.05B $0.02B 32.08%
2018-03-31 $0.06B $0.02B 40.00%
2017-12-31 $0.06B $0.03B 46.67%
2017-09-30 $0.06B $0.03B 52.38%
2017-06-30 $0.07B $0.04B 55.88%
2017-03-31 $0.07B $0.04B 56.72%
2016-12-31 $0.06B $0.04B 55.56%
2016-09-30 $0.06B $0.03B 51.61%
2016-06-30 $0.06B $0.03B 51.72%
2016-03-31 $0.05B $0.02B 48.00%
2015-12-31 $0.05B $0.02B 48.89%
2015-09-30 $0.05B $0.02B 52.17%
2015-06-30 $0.04B $0.02B 51.22%
2015-03-31 $0.04B $0.02B 52.63%
2014-12-31 $0.03B $0.02B 50.00%
2014-09-30 $0.03B $0.01B 44.44%
2014-06-30 $0.02B $0.01B 41.67%
2014-03-31 $0.02B $0.01B 36.36%
2013-12-31 $0.02B $0.01B 31.58%
2013-09-30 $0.01B $0.00B 28.57%
2013-06-30 $0.01B $0.00B 33.33%
2013-03-31 $0.01B $0.00B 40.00%
2012-12-31 $0.01B $0.00B 37.50%
2012-09-30 $0.01B $0.00B 37.50%
2012-06-30 $0.01B $0.00B 37.50%
2012-03-31 $0.01B $0.00B 37.50%
2011-12-31 $0.01B $0.00B 37.50%
2011-09-30 $0.01B $0.00B 37.50%
2011-06-30 $0.01B $0.00B 25.00%
2011-03-31 $0.01B $0.00B 12.50%
2010-12-31 $0.01B $0.00B 14.29%
2010-09-30 $0.01B 0 0.00%
2010-06-30 $0.01B 0 0.00%
2010-03-31 $0.00B 0 0.00%
2009-12-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00